Tamar D Howson, a director of MEI Pharma, just received 50,000 options from the company. The strike price of the options received was $2.95, and these expire on July 01, 2031. Howson now owns at least 50,000 options on the company.
Some additional info was provided as follows:
The options will vest in equal monthly installments over twelve months.
40,000 of the options vested on July 1, 2020, and are currently exercisable and 20,000 options will vest in equal monthly installments over thirty-six months beginning July 1, 2019.
All of such options are presently exercisable.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever MEI Pharma makes a similar move, sign up!